These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 20874422)

  • 41. Genotoxicity guidelines recommended by International Conference of Harmonization (ICH).
    Kamath GH; Rao KS
    Methods Mol Biol; 2013; 1044():431-58. PubMed ID: 23896892
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genotoxicity and carcinogenicity studies of antihistamines.
    Brambilla G; Mattioli F; Robbiano L; Martelli A
    Arch Toxicol; 2011 Oct; 85(10):1173-87. PubMed ID: 21327970
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Minimal analytical characterization of engineered nanomaterials needed for hazard assessment in biological matrices.
    Bouwmeester H; Lynch I; Marvin HJ; Dawson KA; Berges M; Braguer D; Byrne HJ; Casey A; Chambers G; Clift MJ; Elia G; Fernandes TF; Fjellsbø LB; Hatto P; Juillerat L; Klein C; Kreyling WG; Nickel C; Riediker M; Stone V
    Nanotoxicology; 2011 Mar; 5(1):1-11. PubMed ID: 21417684
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nanotoxicology. Preface.
    Doak SH; Pfuhler S
    Mutat Res; 2012 Jun; 745(1-2):1-3. PubMed ID: 22487557
    [No Abstract]   [Full Text] [Related]  

  • 45. Mutagenicity testing for chemical risk assessment: update of the WHO/IPCS Harmonized Scheme.
    Eastmond DA; Hartwig A; Anderson D; Anwar WA; Cimino MC; Dobrev I; Douglas GR; Nohmi T; Phillips DH; Vickers C
    Mutagenesis; 2009 Jul; 24(4):341-9. PubMed ID: 19535363
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity.
    Kirkland D; Aardema M; Henderson L; Müller L
    Mutat Res; 2005 Jul; 584(1-2):1-256. PubMed ID: 15979392
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reports of the 4th International Workshop on Genotoxicity Testing (IWGT). September 9-10, 2005. San Francisco, California, USA.
    Mutat Res; 2007 Feb; 627(1):1-117. PubMed ID: 17342809
    [No Abstract]   [Full Text] [Related]  

  • 48. Perspectives in the use of Drosophila melanogaster in genotoxicity testing.
    Zordan M; Costa R; Levis AG
    Prog Clin Biol Res; 1991; 372():423-31. PubMed ID: 1956936
    [No Abstract]   [Full Text] [Related]  

  • 49. [General problems in the study of the mutagenic properties of drugs].
    Durnev AD; Volgareva GM; Seredenin SB
    Eksp Klin Farmakol; 1998; 61(2):4-12. PubMed ID: 9621164
    [TBL] [Abstract][Full Text] [Related]  

  • 50. How to assess the mutagenic potential of cosmetic products without animal tests?
    Speit G
    Mutat Res; 2009 Aug; 678(2):108-12. PubMed ID: 19379833
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Use of the micronucleus test in the screening and monitoring of mutagens].
    Il'inskikh NN; Il'inskikh IN; Nekrasov VN
    Tsitol Genet; 1988; 22(1):67-72. PubMed ID: 3285552
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Computational prediction of genotoxicity: room for improvement.
    Snyder RD; Smith MD
    Drug Discov Today; 2005 Aug; 10(16):1119-24. PubMed ID: 16182197
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [An evaluation of the genotoxicity of nonionogenic surface-active substances].
    Ivanchenko OB; Il'inskaia ON; Fattakhova AN; Skipina IM; Cherepneva IE
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1992; (1):75-80. PubMed ID: 1299343
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Genotoxicity research thought and method on traditional Chinese medicine].
    Han JY; Yi Y; Liang AH; Zhang YS; Li CY; Zhao Y; Wang LM; Li GQ
    Zhongguo Zhong Yao Za Zhi; 2015 Jul; 40(14):2696-700. PubMed ID: 26666011
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Assessment of mechanisms driving non-linear dose-response relationships in genotoxicity testing.
    Guérard M; Baum M; Bitsch A; Eisenbrand G; Elhajouji A; Epe B; Habermeyer M; Kaina B; Martus HJ; Pfuhler S; Schmitz C; Sutter A; Thomas AD; Ziemann C; Froetschl R
    Mutat Res Rev Mutat Res; 2015; 763():181-201. PubMed ID: 25795120
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clastogenicity, photo-clastogenicity or pseudo-photo-clastogenicity: Genotoxic effects of zinc oxide in the dark, in pre-irradiated or simultaneously irradiated Chinese hamster ovary cells.
    Dufour EK; Kumaravel T; Nohynek GJ; Kirkland D; Toutain H
    Mutat Res; 2006 Sep; 607(2):215-24. PubMed ID: 16797222
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vivo genotoxicity assessment of aluminium oxide nanomaterials in rat peripheral blood cells using the comet assay and micronucleus test.
    Balasubramanyam A; Sailaja N; Mahboob M; Rahman MF; Hussain SM; Grover P
    Mutagenesis; 2009 May; 24(3):245-51. PubMed ID: 19237533
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genotoxicity test system based on p53R2 gene expression in human cells: examination with 80 chemicals.
    Ohno K; Tanaka-Azuma Y; Yoneda Y; Yamada T
    Mutat Res; 2005 Dec; 588(1):47-57. PubMed ID: 16236544
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Assessment of the sensitivity of the computational programs DEREK, TOPKAT, and MCASE in the prediction of the genotoxicity of pharmaceutical molecules.
    Snyder RD; Pearl GS; Mandakas G; Choy WN; Goodsaid F; Rosenblum IY
    Environ Mol Mutagen; 2004; 43(3):143-58. PubMed ID: 15065202
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Manufactured nanomaterials: categorization and approaches to hazard assessment.
    Gebel T; Foth H; Damm G; Freyberger A; Kramer PJ; Lilienblum W; Röhl C; Schupp T; Weiss C; Wollin KM; Hengstler JG
    Arch Toxicol; 2014 Dec; 88(12):2191-211. PubMed ID: 25326817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.